What are the causes of bicytopenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Bicytopenia

Primary Etiological Categories

Bicytopenia results from four major categories: non-malignant hematologic disorders (most common), infectious diseases, malignant conditions, and drug-induced causes. 1

Non-Malignant Hematologic Disorders (56% of cases)

  • Megaloblastic anemia is the predominant non-malignant cause of bicytopenia, resulting from vitamin B12 or folate deficiency affecting erythrocyte and leukocyte production 1
  • Immune thrombocytopenic purpura (ITP) frequently presents with bicytopenia when combined with anemia from bleeding or autoimmune hemolysis 2, 1
  • Aplastic anemia causes pancytopenia through immune-mediated destruction of hematopoietic stem cells, but may initially present as bicytopenia 3, 4
  • Alcoholic liver disease produces bicytopenia through multiple mechanisms including direct marrow toxicity, hypersplenism, and nutritional deficiencies 1
  • Myelodysplastic syndromes (MDS) characteristically present with refractory cytopenias affecting one or two lineages before progressing to pancytopenia 5

Infectious Causes (31.7% of cases)

  • Dengue fever is the most common infectious cause (12% of all bicytopenia cases), producing thrombocytopenia with leukopenia through direct viral bone marrow suppression 1, 6
  • HIV infection causes bicytopenia through multiple mechanisms including direct marrow suppression, immune-mediated destruction, and opportunistic infections 5, 7
  • Hepatitis C virus (HCV) produces thrombocytopenia with anemia that is clinically indistinguishable from primary ITP 2, 8
  • Parvovirus B19 causes red cell aplasia with associated leukopenia, particularly in immunocompromised patients 4
  • Miliary tuberculosis produces bicytopenia through bone marrow infiltration and granuloma formation 4
  • Cytomegalovirus (CMV) infection leads to cytopenias including bicytopenia through direct marrow suppression 7

Malignant Conditions (8.3% of cases)

  • Acute lymphoblastic leukemia (ALL) presents with bicytopenia when blast infiltration suppresses normal hematopoiesis while one cell line remains relatively preserved 4, 1
  • Chronic lymphocytic leukemia (CLL) causes bicytopenia through bone marrow infiltration or autoimmune mechanisms, with autoimmune cytopenias occurring more commonly than granulocytopenia 7
  • Lymphoma produces bicytopenia through marrow infiltration, hypersplenism, or autoimmune mechanisms 5, 1
  • Myelodysplastic syndromes are classified by the WHO as refractory cytopenia with unilineage or multilineage dysplasia, frequently presenting as bicytopenia before progression 5

Drug-Induced Causes (4% of cases)

  • Chemotherapy agents commonly cause bone marrow suppression leading to bicytopenia or pancytopenia through direct cytotoxic effects 5, 7
  • Immune checkpoint inhibitors induce hematologic immune-related adverse events including bicytopenia in up to 70% of patients receiving CAR T-cell therapy 5
  • Azathioprine and 6-mercaptopurine cause bone marrow toxicity with leukopenia in approximately 3.2% of patients, with severe cases occurring in 5.3% of rheumatoid arthritis patients 7
  • Immunosuppressive medications used in autoimmune disorders and post-transplant settings produce bicytopenia through direct marrow suppression 7
  • Heparin causes thrombocytopenia with associated anemia in heparin-induced thrombocytopenia (HIT), typically occurring 5-10 days after initiation 2

Autoimmune and Systemic Diseases

  • Systemic lupus erythematosus (SLE) produces bicytopenia through autoimmune destruction of blood cells, with peripheral cytopenias being common but bone marrow involvement rarely reported 3, 4
  • Antiphospholipid syndrome causes thrombocytopenia with associated anemia through thrombotic microangiopathy mechanisms 2
  • Common variable immunodeficiency (CVID) presents with ITP as a feature, potentially causing bicytopenia when combined with anemia 2

Specific Bicytopenia Patterns and Their Significance

Anemia with Thrombocytopenia (61% of bicytopenia cases)

  • This is the most common bicytopenia pattern, typically seen in megaloblastic anemia, ITP with bleeding, alcoholic liver disease, and MDS 1
  • Pallor, bleeding, hepatomegaly, and splenomegaly are the most frequent clinical signs in non-malignant conditions causing this pattern 1

Anemia with Leukopenia (26% of bicytopenia cases)

  • This pattern suggests bone marrow infiltration, nutritional deficiencies (particularly B12/folate), or viral infections affecting both erythroid and myeloid lineages 1
  • Fever and lymphadenopathy are most frequently associated with infectious causes of this pattern 1

Leukopenia with Thrombocytopenia (13% of bicytopenia cases)

  • This pattern is characteristic of viral infections (especially dengue), drug-induced marrow suppression, and early aplastic anemia 1, 6
  • Lymphadenopathy, splenomegaly, and hepatomegaly are most significantly associated with hematological malignancies presenting with this pattern 1

Age-Specific Considerations

  • Pediatric bicytopenia occurs in 6% of neonates, 7% of infants, 25% of children, and 17% of teenagers, with infections being the predominant cause (65.84%) 4, 1, 6
  • Adult bicytopenia (85% of cases) most commonly results from non-malignant causes, particularly megaloblastic anemia and alcoholic liver disease 1
  • Elderly patients (>60 years) with bicytopenia require bone marrow examination to exclude myelodysplastic syndromes, leukemias, or other malignancies 2, 8

Critical Diagnostic Red Flags

  • Lymphadenopathy, splenomegaly, and hepatomegaly are most significantly associated with hematological malignancies (p < 0.001) and mandate immediate bone marrow evaluation 1
  • Systemic symptoms including fever, weight loss, night sweats, or bone pain suggest malignancy or systemic disease rather than isolated hematologic disorders 8, 1
  • Severe cytopenia at presentation correlates with more serious underlying etiologies, with pancytopenia showing more severe cell line depression than bicytopenia 6

Iatrogenic and Treatment-Related Causes

  • CAR T-cell therapy produces prolonged cytopenias including bicytopenia in weeks to months after infusion, with factors including CRS severity, disease burden, and prior therapies contributing 5
  • Post-transplant immunosuppression causes bicytopenia through direct marrow suppression, with graft failure resulting in severe leukopenia and mortality up to 80% 7
  • Corticosteroid treatment for immune-related adverse events can paradoxically worsen cytopenias while treating the underlying inflammatory condition 5

Nutritional Deficiencies

  • Vitamin B12 and folate deficiency cause megaloblastic anemia with associated leukopenia, representing the predominant non-malignant cause of bicytopenia 1
  • Copper deficiency can cause cytopenias including bicytopenia through impaired hematopoiesis 9

Hypersplenism and Portal Hypertension

  • Alcoholic liver disease with portal hypertension produces bicytopenia through hypersplenism, direct marrow toxicity, and nutritional deficiencies 1
  • Moderate or massive splenomegaly indicates alternative diagnoses such as lymphoproliferative disease or portal hypertension rather than primary hematologic disorders 8

References

Guideline

Thrombocytopenia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Leukocytopenia Causes and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chronic Thrombocytopenia Workup

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Herbal approach in the treatment of pancytopenia.

Journal of complementary & integrative medicine, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.